Modus's Intended IPO to Spur Sickle Cell Drug R&D

 
• By John Davis
  
Sickle cell anemia, 3D illustration showing blood vessel with normal and deformated crescent-like red blood cells
• Source: Shutterstock, Kateryna Kon
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Financing

More from Business